Adjuvant drug therapy
Clinical trials for Adjuvant drug therapy explained in plain language.
Never miss a new study
Get alerted when new Adjuvant drug therapy trials appear
Sign up with your email to follow new studies for Adjuvant drug therapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could tailored tamoxifen doses keep more breast cancer patients on treatment?
Disease control Recruiting nowThis phase 3 trial tests whether adjusting tamoxifen doses based on individual metabolism can reduce the number of breast cancer patients who stop treatment early due to side effects. About 1,100 premenopausal or perimenopausal women with hormone-sensitive breast cancer will rece…
Matched conditions: ADJUVANT DRUG THERAPY
Phase 3 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for lung cancer patients whose drugs have failed
Disease control Recruiting nowThis study is for people with advanced non-small cell lung cancer that has stopped responding to a type of targeted therapy called third-generation EGFR TKIs. Researchers want to see if giving chemotherapy first, followed by a newer targeted drug called befotertinib, can help con…
Matched conditions: ADJUVANT DRUG THERAPY
Phase 2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New study aims to tailor breast cancer treatment for patients over 70
Knowledge-focused Recruiting nowThis study follows 200 breast cancer patients aged 70 and older who are starting a type of targeted therapy called CDK4/6 inhibitors combined with hormone therapy. The goal is to see how well geriatric screening tools can predict side effects and quality of life changes. Research…
Matched conditions: ADJUVANT DRUG THERAPY
Sponsor: Region Jönköping County • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC